Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent. - Desborough MJR; Mitchell JL; Whitworth P; Al Juwaiser A; Sage T; Kriek N; Little G; Vaiyapuri S; Gibbins JM; Bye AP (Haematologica, 2026)